CAS 245080-24-4

2-((6S,15S,18S,27S,35S,38S,41S,43aS,48aS)-12-(4-aminobutyl)-35-benzyl-6,41-di((S)-sec-butyl)-21-(3-guanidinopropyl)-15-((R)-1-hydroxyethyl)-9-(hydroxymethyl)-5,8,11,14,17,20,23,26,29,34,37,40,43,48-tetradecaoxohexatetracontahydro-1H,5H-18,38-(methanodithiomethano)tripyrrolo[1,2-a:1',2'-b1:1'',2''-e1][1,4,7,10,13,16,19,22,25,28,31,34,37,40]tetradecaazacyclodotetracontin-27-yl)acetic acid

Description:

The chemical substance known as "2-((6S,15S,18S,27S,35S,38S,41S,43aS,48aS)-12-(4-aminobutyl)-35-benzyl-6,41-di((S)-sec-butyl)-21-(3-guanidinopropyl)-15-((R)-1-hydroxyethyl)-9-(hydroxymethyl)-5,8,11,14,17,20,23,26,29,34,37,40,43,48-tetradecaoxohexatetracontahydro-1H,5H-18,38-(methanodithiomethano)tripyrrolo[1,2-a:1',2'-b1:1'',2''-e1][1,4,7,10,13,16,19,22,25,28,31,34,37,40]tetradecaazacyclodotetracontin-27-yl)acetic acid" (CAS 245080-24-4) is a complex organic compound characterized by its intricate multi-ring structure and numerous functional groups. This substance features multiple stereocenters, indicating significant chirality, which may influence its biological activity and interactions. The presence of amine, guanidine, and hydroxyl groups suggests potential for hydrogen bonding and solubility in polar solvents. Its large molecular size and extensive functionalization imply that it may exhibit unique pharmacological properties, possibly serving as a candidate for therapeutic applications. The compound's structural complexity may also pose challenges in synthesis and characterization, requiring advanced techniques for analysis. Overall, this substance exemplifies the diversity and intricacy found in organic chemistry, particularly in the realm of biologically active molecules.

Formula: C₆₇H₁₀₄N₁₈O₁₈S₂

Synonyms:

• Cyclo(L-arginyl-L-cysteinyl-L-threonyl-L-lysyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-isoleucyl-L-cysteinyl-L-phenylalanyl-L-prolyl-L-α-aspartylglycyl), cyclic (2→10)-disulfide
• 2-((6S,15S,18S,27S,35S,38S,41S,43aS,48aS)-12-(4-aminobutyl)-35-benzyl-6,41-di((S)-sec-butyl)-21-(3-guanidinopropyl)-15-((R)-1-hydroxyethyl)-9-(hydroxymethyl)-5,8,11,14,17,20,23,26,29,34,37,40,43,48-tetradecaoxohexatetracontahydro-1H,5H-18,38-(methanodithi
• SFTI-1
• 2-((6S,15S,18S,27S,35S,38S,41S,43aS,48aS)-12-(4-aminobutyl)-35-benzyl-6,41-di((S)-sec-butyl)-21-(3-guanidinopropyl)-15-((R)-1-hydroxyethyl)-9-(hydroxymethyl)-5,8,11,14,17,20,23,26,29,34,37,40,43,48-tetradecaoxohexatetracontahydro-1H,5H-18,38-(methanodithiomethano)tripyrrolo[1,2-a:1',2'-b1:1'',2''-e1][1,4,7,10,13,16,19,22,25,28,31,34,37,40]tetradecaazacyclodotetracontin-27-yl)acetic acid

SFTI-1

CAS: 245080-24-4

SFTI-1, a cyclic peptide trypsin inhibitor comprising 14 amino acid residues, is a potent Bowman-Birk inhibitor.

Formula: C₆₇H₁₀₄N₁₈O₁₈S₂

Color and Shape: Solid

Molecular weight: 1513.78

Ref: TM-TP2622